Clinical trial analysis of 2019‐nCoV therapy registered in China

So far, there is a lack of effective drugs for the new coronavirus pneumonia. With more and more patients diagnosed, China has carried out more than 100 clinical studies of new coronavirus infection, including antiviral drugs, antimalarial drugs, glucocorticoids, plasma therapy, virus vaccine, and o...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of medical virology 2020-06, Vol.92 (6), p.540-545
Hauptverfasser:	Zhang, Qi, Wang, Yakun, Qi, Changsong, Shen, Lin, Li, Jian
Format:	Artikel
Sprache:	eng
Schlagworte:	Adenosine Monophosphate - analogs & derivatives Adenosine Monophosphate - therapeutic use Alanine - analogs & derivatives Alanine - therapeutic use Amides - therapeutic use Antiviral agents Antiviral Agents - therapeutic use Betacoronavirus - drug effects Betacoronavirus - genetics Betacoronavirus - pathogenicity China China - epidemiology Chloroquine - analogs & derivatives Chloroquine - therapeutic use clinical trial Clinical trials Clinical Trials as Topic Coronaviridae Coronavirus Infections - diagnosis Coronavirus Infections - drug therapy Coronavirus Infections - epidemiology Coronavirus Infections - virology Coronaviruses COVID-19 Disease Management Disease Outbreaks Drugs Drugs, Chinese Herbal - therapeutic use Glucocorticoids Herbal medicine Humans Medicine, Chinese Traditional - methods new coronavirus pneumonia new drugs Nucleic acids Pandemics Pneumonia, Viral - diagnosis Pneumonia, Viral - drug therapy Pneumonia, Viral - epidemiology Pneumonia, Viral - virology Practice Guidelines as Topic Pyrazines - therapeutic use SARS-CoV-2 Vaccines Viral diseases Virology Viruses
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!